SCHEMBL21474157

SCHEMBL21474157

Cn1c(=O)n(-c2ccc(NCCO)nc2)c2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ MAPK8 P45983 1/20 0.38
▸ MAP4K1 Q92918 1/20 0.38
▸ TSHR P16473 1/20 0.37
▸ BTK Q06187 1/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ THRB P10828 2/20 0.37
▸ USP2 O75604 1/20 0.37
▸ HSP90AA1 P07900 1/20 0.37
▸ HSP90AB1 P08238 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ CASP1 P29466 1/20 0.37
▸ BRCA1 P38398 1/20 0.37
▸ HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24405889 0.87 HCAR3 (0.45) POLBKDM4EMAP4K1MEN1LMNA
SCHEMBL24405980 0.82 PGR (0.43) ALDH1A1KDM4EMAP4K1TSHRLMNA
SCHEMBL21474172 0.80 PTK2 (0.44) ALDH1A1KDM4EGAAMAP4K1TSHR
SCHEMBL23119775 0.80 HSD17B10 (0.46) POLBALDH1A1MAP4K1TSHRLMNA
SCHEMBL29581561 0.77 AURKA (0.46) MAPK8MAP4K1LMNAHSP90AA1MAPT
SCHEMBL27261699 0.77 HCAR3 (0.46) POLBMAP4K1MEN1KMT2APIK3CA
SCHEMBL24405682 0.77 PGR (0.36) MAP4K1TSHRMEN1KMT2ASMN1; SMN2
SCHEMBL27253472 0.77 PCSK9 (0.33) MAP4K1PIK3CAPRKDCGSK3BMTOR
SCHEMBL29311983 0.77 PCSK9 (0.33) MAP4K1PIK3CAPRKDCGSK3BMTOR
SCHEMBL21474179 0.76 GAA (0.39) ALDH1A1GAATSHRMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019198692-A1 FUSED CYCLIC UREA DERIVATIVES AS CRHR2 ANTAGONIST RAQUALIA PHARMA INC. (JP) 2019-10-17 — — WO disclosed
Send feedback